Clinical Trial Update: Clinical And Radiographic Evaluation Of Premixed Bio-ceramic MTA In Indirect Pulp Capping Of Young Permanent Molars [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating premixed bio-ceramic MTA for indirect pulp capping in young permanent molars; status not specified in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indirect Pulp Necrosis Indirect Pulp Exposure Indirect Pulp Capping Is the Procedure Disease Naming Is Indirect Pulp Capping Condition Is Not Disease Based On Provided Info the Disease Field Is Empty

Drugs mentioned

• premixed bio-ceramic MTA

Snippet

Sponsor: Cairo University | Conditions: Indirect Pulp Capping | Phase 3 | Status: UNKNOWN